These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 4573873
21. Effect of 4-demethoxydaunorubicin (4-DMDR) in chronic myeloid leukemia in blastic transformation and relapsed acute leukemias. Bandini G, Comotti B, Scapoli G, Leoni F, Di Prisco U, Mangoni L, Battista R, Tura S. Haematologica; 1985; 70(2):155-9. PubMed ID: 3924779 [No Abstract] [Full Text] [Related]
24. [Treatment of acute myeloblastic leukemia]. Jacquillat C, Weil M, Gemon MF. Therapeutique; 1973 Mar; 49(3):221-5. PubMed ID: 4517257 [No Abstract] [Full Text] [Related]
25. Daunorubicin in the treatment of adult acute leukaemia. Burgess MA, Garson OM, de Gruchy GC. Med J Aust; 1970 Mar 28; 1(13):629-35. PubMed ID: 5267172 [No Abstract] [Full Text] [Related]
26. Treatment of AGL. Lee SL, Rosner F. Arch Intern Med; 1969 Feb 28; 123(2):205-6. PubMed ID: 5249563 [No Abstract] [Full Text] [Related]
27. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Hofland KF, Thougaard AV, Sehested M, Jensen PB. Clin Cancer Res; 2005 May 15; 11(10):3915-24. PubMed ID: 15897593 [Abstract] [Full Text] [Related]
33. [The role of zorubicine in the treatment of acute myeloid leukemia. Evaluation of 15 years' use]. Marty M, Gisselbrecht C, Schaison G, Bauters F, Guy H, Bordessoule D, Lepage E, Gemont-Auclerc MF, Boiron M. Pathol Biol (Paris); 1987 Feb 15; 35(2):133-7. PubMed ID: 3550620 [No Abstract] [Full Text] [Related]
34. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. Evans AE, Baehner RL, Chard RL, Leikin SL, Pang EM, Pierce M. Cancer Chemother Rep; 1974 Feb 15; 58(5 Pt 1):671-6. PubMed ID: 4371948 [No Abstract] [Full Text] [Related]
35. Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia. Sackmann Muriel F, Pavlovsky S, Peñalver JA, Hidalgo G, Cebrian Bonesana A, Eppinger-Helft M, De Macchi GH, Pavlovsky A. Cancer; 1974 Aug 15; 34(2):418-26. PubMed ID: 4527793 [No Abstract] [Full Text] [Related]
36. [Trial of adriamycin in the treatment of acute leukemia]. Mathé G, Amiel JL, Hayat M, de Vassal F, Schwarzenberg L, Schneider M, Jasmin C, Rosenfeld C. Presse Med (1893); 1970 Oct 31; 78(46):1997-9. PubMed ID: 5274058 [No Abstract] [Full Text] [Related]